Therapeutic effects of muscovite to non-steroidal anti-inflammatory drugs-induced small intestinal disease.

[1]  C. Sakamoto,et al.  Distribution of small intestinal mucosal injuries as a result of NSAID administration , 2010, European journal of clinical investigation.

[2]  Toshio Watanabe,et al.  Present status and strategy of NSAIDs-induced small bowel injury , 2009, Journal of Gastroenterology.

[3]  Wei-Li Liu,et al.  Therapeutic effects of rectal administration of muscovite on experimental colitis in rats , 2009, Journal of gastroenterology and hepatology.

[4]  K. Tominaga,et al.  Evaluation of Small Bowel Injury in Patients with Rheumatoid Arthritis by Capsule Endoscopy: Effects of Anti-Rheumatoid Arthritis Drugs , 2009, Digestion.

[5]  K. Tominaga,et al.  Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  K. Tominaga,et al.  A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding , 2008, Journal of Gastroenterology.

[7]  K. Sugano,et al.  Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: A Japanese multicenter study , 2008, Scandinavian journal of gastroenterology.

[8]  Y. Hirooka,et al.  Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study , 2008, Journal of Gastroenterology.

[9]  C. Sakamoto,et al.  Diagnosis and treatment of obscure gastrointestinal bleeding using combined capsule endoscopy and double balloon endoscopy: 1-year follow-up study , 2007, Endoscopy.

[10]  A. Seigal,et al.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  R. Sidhu,et al.  Capsule endoscopy for the evaluation of nonsteroidal anti-inflammatory drug-induced enteropathy: United Kingdom pilot data. , 2006, Gastrointestinal endoscopy.

[12]  J. Baron,et al.  A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. , 2006, Gastroenterology.

[13]  Á. Lanas,et al.  Microbial Flora in NSAID-Induced Intestinal Damage: A Role for Antibiotics? , 2006, Digestion.

[14]  Shu-jie Chen,et al.  [Intestinal mucosa protection of muscovite n ulcerative colitis in rats]. , 2005, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[15]  J. Si,et al.  [The effect of muscovite on the quality of gastric ulcer healing]. , 2005, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[16]  D. Graham,et al.  Visible small-intestinal mucosal injury in chronic NSAID users. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  T. Schnitzer,et al.  Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial , 2004, The Lancet.

[18]  Shu-jie Chen,et al.  [Mechanisms of muscovite on gastric mucosal protective effect]. , 2004, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[19]  K. Sugano,et al.  Total enteroscopy with a nonsurgical steerable double-balloon method. , 2001, Gastrointestinal endoscopy.

[20]  J. Bolognese,et al.  COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin , 2000, Gut.

[21]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[22]  A. Püspök,et al.  Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon , 2000, Diseases of the colon and rectum.

[23]  E. O'Loughlin,et al.  The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit , 1999, Gut.

[24]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[25]  J. Wallace,et al.  Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.

[26]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.